MSB 3.33% $1.40 mesoblast limited

Ann: FDA Grants Orphan Drug Designation for Revascor, page-121

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,135 Posts.
    lightbulb Created with Sketch. 304
    I think we will see less of you in the months ahead. You have done well with PNV and anyone in that has invested on the new and growing returns as I have also.
    I also admit my loss here but I stand by it.
    I will not sell, and I hold a good portion.
    I might be on the top 20 list if it drops to my next buy point.
    The computer does that, I don't.
    No emotion when you commit.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.